“They put an IV in your arm, and the first medicine that goes through puts you to sleep. And the second one stops all body functions,” Hendrix said. “They have some kind of button on the IV. You have ...
Merck and Daiichi Sankyo's HER3 antibody-drug conjugate reported a positive phase 3 result in EGFR-mutated lung cancer. Merck ...
Patients with vs without rheumatoid arthritis (RA), especially those with RA-associated interstitial lung disease (RA-ILD), have a significantly higher risk of developing lung cancer, according to ...
The US FDA has approved Kisqali (ribociclib) for treating early-stage breast cancer in combination with hormone therapy. It ...
AbbVie (NYSE: ABBV) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the marketing ...
The following is a summary of “Evaluating sensitization-associated, neuropathic-like symptoms and psychological factors in ...
The positive phase 3 results showed improved lung function with nerandomilast vs placebo at 52 weeks in idiopathic pulmonary ...
Rice University and Baylor College of Medicine have received $2.8 million in funding from the National Heart, Lung, and Blood Institute (NHLBI), a division of the National ...
The route of abatacept administration does not appear to impact its efficacy when treating rheumatoid arthritis-associated interstitial lung disease. The route of abatacept (ABA) administration does ...
Findings of a systematic review highlight the need for standardized assessment tools and targeted treatments for chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback